Danielle Ellis

Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

Authors describe a FO-SPR assay capable of detecting EVs with LODs 103 times lower than the expected physiological concentration of EVs in healthy human plasma and 104 times lower than EV concentration in the plasma of cancer patients.

BIOHIT HealthCare is attending BSG LIVE′24 at ICC Birmingham from the 17th to the 20th of June, where it will be showcasing its broad range of gastrointestinal diagnostic solutions.

ePrep is delighted to announce a new partnership with Agilent – a global leader in technology platforms for analytical laboratories – for the distribution of the ePrep® ONE workstation in selected regions.

A modeling study estimates cancer screening costs in the United States exceed $40 billion annually, highlighting the need for policy prioritization to enhance equitable access. The study emphasizes that recommended screenings significantly reduce cancer-specific mortality and can be cost-effective.

WHO has declared the upsurge of mpox in the DRC and other African countries as a public health emergency of international concern, citing its potential for further spread and the urgent need for coordinated global action.

Bettersize's upcoming webinar will delve into particle size and zeta potential, showcasing their importance in pharmaceutical development and product quality.

Engage with over 2000 attendees at the World Orphan Drug Congress Europe, focusing on gene therapy and strategies for rare disease treatment advancements.

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief solutions at ELRIG Drug Discovery 2024.

Research links cesarean sections during labor to increased risks of recurrent preterm birth and mid-trimester loss, highlighting cervical damage concerns.